These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30012587)

  • 1. Penetrance of phaeochromocytoma in
    Maciel RMB; Bim LV; Camacho CP; Cerutti JM
    Endocr Relat Cancer; 2018 Sep; 25(9):L49-L51. PubMed ID: 30012587
    [No Abstract]   [Full Text] [Related]  

  • 2. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
    Machens A; Dralle H
    Surgery; 2008 May; 143(5):696; author reply 697. PubMed ID: 18436021
    [No Abstract]   [Full Text] [Related]  

  • 4. The penetrance of MEN2 pheochromocytoma is not only determined by
    Castinetti F; Maia AL; Peczkowska M; Barontini M; Hasse-Lazar K; Links TP; Toledo RA; Dvorakova S; Mian C; Bugalho MJ; Zovato S; Alevizaki M; Kvachenyuk A; Bausch B; Loli P; Bergmann SR; Patocs A; Pfeifer M; Costa JB; von Dobschuetz E; Letizia C; Valk G; Barczynski M; Czetwertynska M; Plukker JTM; Sartorato P; Zelinka T; Vlcek P; Yaremchuk S; Weryha G; Canu L; Wohllk N; Sebag F; Walz MK; Eng C; Neumann HPH
    Endocr Relat Cancer; 2017 Aug; 24(8):L63-L67. PubMed ID: 28649091
    [No Abstract]   [Full Text] [Related]  

  • 5. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
    Pinna G; Ghiani M; Mariotti S
    Clin Endocrinol (Oxf); 2008 May; 68(5):836. PubMed ID: 17970769
    [No Abstract]   [Full Text] [Related]  

  • 6. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
    Quayle FJ; Fialkowski EA; Benveniste R; Moley JF
    Surgery; 2007 Dec; 142(6):800-5; discussion 805.e1. PubMed ID: 18063059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
    Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report.
    Mavromati M; Amsallem M; Jublanc C; Bruckert E; Leenhardt L; Girerd X
    Ann Endocrinol (Paris); 2015 Dec; 76(6):690-4. PubMed ID: 26639185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-oriented approach to hereditary adrenal pheochromocytoma.
    Machens A; Brauckhoff M; Gimm O; Dralle H
    Ann N Y Acad Sci; 2006 Aug; 1073():417-28. PubMed ID: 17102110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of RET genetic variants in MEN2-associated pheochromocytoma.
    Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
    Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic basis of pheochromocytoma: who to screen and how?
    Plouin PF; Gimenez-Roqueplo AP
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):60-1. PubMed ID: 16932255
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolent medullary thyroid cancer with a RET proto-oncogene Cys618Phe mutation presenting as sporadic unilateral pheochromocytoma in a 55-year-old Korean woman.
    Kim DD; Croxson MS; Cranshaw IM; Evans JL; Marquis-Nicholson R; Love DR
    Thyroid; 2011 Mar; 21(3):325-6. PubMed ID: 21254918
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades.
    Mucha L; Leidig-Bruckner G; Frank-Raue K; Bruckner T; Kroiss M; Raue F;
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):320-326. PubMed ID: 28605116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of phaeochromocytoma tumours in RET mutation carriers - a single-centre study.
    Kotecka-Blicharz A; Hasse-Lazar K; Jurecka-Lubieniecka B; Pawlaczek A; Oczko-Wojciechowska M; Bugajska B; Ledwon A; Król A; Michalik B; Jarząb B
    Endokrynol Pol; 2016; 67(1):54-8. PubMed ID: 26884116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
    Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET mutation screening in sporadic pheochromocytoma.
    Arnold A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):430. PubMed ID: 8550789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.